Literature DB >> 17452816

Angiotropic melanoma and extravascular migratory metastasis: a review.

Claire Lugassy1, Raymond L Barnhill.   

Abstract

How metastases develop is poorly understood. The concept of intravascular dissemination of cancer cells has been widely accepted as a central paradigm. In addition to this explanation, however, other mechanisms may be operable. Ultrastructural studies have identified in malignant melanoma an angio-tumoral complex, in which tumor cells are linked to endothelium by a matrix containing laminin without evidence of intravasation. This observation has suggested that melanoma cells may migrate along the external surface of vessels and other anatomic structures, a mechanism termed "extravascular migratory metastasis" (EVMM). Angiotropism (melanoma cells cuffing the external surface of vessels) is the histopathologic counterpart of the angio-tumoral complex. The authors have recently drawn attention to the importance of angiotropism as a biologic phenomenom and prognostic factor in melanoma and as a likely correlate of EVMM. In addition, recent experimental studies strongly suggest a correlation of angiotropism of melanoma cells with EVMM. These studies, including cocultures of melanoma cells with capillarylike structures in vitro and the growth of green fluorescent protein-labeled melanoma cells in the shell-less chick chorioallantoic membrane model, have demonstrated the migration of angiotropic melanoma cells along the vascular channels, supporting the concept of EVMM. The new field of EVMM reviewed in this paper may prove useful in elucidating the molecular interactions involved in melanoma metastasis.

Entities:  

Mesh:

Year:  2007        PMID: 17452816     DOI: 10.1097/PAP.0b013e31805048d9

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  24 in total

1.  Epithelial cell guidance by self-generated EGF gradients.

Authors:  Cally Scherber; Alexander J Aranyosi; Birte Kulemann; Sarah P Thayer; Mehmet Toner; Othon Iliopoulos; Daniel Irimia
Journal:  Integr Biol (Camb)       Date:  2012-02-08       Impact factor: 2.192

2.  Architecture and migration of an epithelium on a cylindrical wire.

Authors:  Hannah G Yevick; Guillaume Duclos; Isabelle Bonnet; Pascal Silberzan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-28       Impact factor: 11.205

3.  Spitzoid melanoma of childhood: a case series and review.

Authors:  Sandeep Batra
Journal:  Melanoma Manag       Date:  2015-05-18

4.  'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.

Authors:  Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Exp Ther Med       Date:  2011-02-28       Impact factor: 2.447

5.  Spontaneous migration of cancer cells under conditions of mechanical confinement.

Authors:  Daniel Irimia; Mehmet Toner
Journal:  Integr Biol (Camb)       Date:  2009-07-16       Impact factor: 2.192

6.  An electro-osmotic microfluidic system to characterize cancer cell migration under confinement.

Authors:  T H Hui; W C Cho; H W Fong; M Yu; K W Kwan; K C Ngan; K H Wong; Y Tan; S Yao; H Jiang; Z Gu; Y Lin
Journal:  J R Soc Interface       Date:  2019-06-05       Impact factor: 4.118

Review 7.  Cancer cell motility: lessons from migration in confined spaces.

Authors:  Colin D Paul; Panagiotis Mistriotis; Konstantinos Konstantopoulos
Journal:  Nat Rev Cancer       Date:  2016-12-02       Impact factor: 60.716

8.  Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Authors:  Andrea P Moy; Lyn M Duncan; Stefan Kraft
Journal:  Lab Invest       Date:  2016-12-19       Impact factor: 5.662

9.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10

10.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.